|
|||||
|
|
Formulations of hormone therapy and risk of Parkinson's disease |
|
| Authors: | Jessica I. Lundin MPH Thanh G.N. Ton PhD Andrea Z. LaCroix PhD W.T. Longstreth MD MPH Gary M. Franklin MD MPH Phillip D. Swanson MD PhD Terri Smith‐Weller RN MN COHN‐S Brad A. Racette MD Harvey Checkoway PhD |
| Affiliation: | 1. Department of Environmental and Occupational Health Sciences, University of Washington, , Seattle, Washington, USA;2. Department of Neurology, University of Washington, , Seattle, Washington, USA;3. Department of Family and Preventive Medicine, University of California San Diego, , La Jolla, California, USA;4. Department of Epidemiology, University of Washington, , Seattle, Washington, USA;5. Department of Neurology, Washington University, , St. Louis, Missouri, USA |
| Abstract: | |
| Keywords: | hormone therapy estrogen therapy Parkinson's disease neurodegenerative disease epidemiology |